We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.49%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$58.1B
AUM Growth
+$5.28B
(+10%)
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
1.82%
Top 10 Holdings %
Top 10 Hldgs %
14.06%
Holding
4,799
New
857
Increased
1,497
Reduced
1,529
Closed
854
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$701M |
| 2 |
Pinduoduo
PDD
|
+$159M |
| 3 |
CrowdStrike
CRWD
|
+$152M |
| 4 |
UnitedHealth
UNH
|
+$143M |
| 5 |
SPDR Gold Trust
GLD
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.17B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$240M |
| 3 |
Microsoft
MSFT
|
+$184M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 5 |
Ulta Beauty
ULTA
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.49% |
| 2 | Consumer Discretionary | 6.34% |
| 3 | Healthcare | 4.58% |
| 4 | Financials | 4.54% |
| 5 | Industrials | 3.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Moderna
MRNA
$22.1B
| $959K | ﹤0.01% |
8,996
-142,320
| -94% | -$14.3M |
|
2627
PUT
Novartis
NVS
$297B
| $958K | ﹤0.01% |
+9,900
| New | +$1.02M |
|
2628
CALL
Axos Financial
AX
$5.45B
| $957K | ﹤0.01% |
17,700
| – | – |
|
2629
CALL
Corpay
CPAY
$24.8B
| $956K | ﹤0.01% |
3,100
+2,100
| +210% | +$603K |
|
2630
ABM Industries
ABM
$2.84B
| $956K | ﹤0.01% |
+21,434
| New | +$898K |
|
2631
Krispy Kreme
DNUT
$562M
| $951K | ﹤0.01% |
62,431
+22,791
| +57% | +$304K |
|
2632
Cohen & Steers
CNS
$4.17B
| $950K | ﹤0.01% |
12,352
+902
| +8% | +$64.4K |
|
2633
UroGen Pharma
URGN
$2.02B
| $946K | ﹤0.01% |
63,039
+3,349
| +6% | +$54.7K |
|
|
OLK
2634
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $945K | ﹤0.01% |
+40,209
| New | +$970K |
|
2635
Dream Finders Homes
DFH
$1.43B
| $944K | ﹤0.01% |
21,588
-28,772
| -57% | -$1.01M |
|
2636
Virtu Financial
VIRT
$5.12B
| $943K | ﹤0.01% |
45,972
-106,896
| -70% | -$1.97M |
|
2637
CALL
Glaukos
GKOS
$8.92B
| $943K | ﹤0.01% |
+10,000
| New | +$893K |
|
|
HRT
2638
DELISTED
HireRight Holdings Corporation
HRT
| $942K | ﹤0.01% |
65,978
+49,849
| +309% | +$668K |
|
2639
The RealReal
REAL
$1.4B
| $940K | ﹤0.01% |
240,415
+178,957
| +291% | +$426K |
|
2640
CALL
Telephone and Data Systems
TDS
$3.83B
| $936K | ﹤0.01% |
+58,400
| New | +$997K |
|
2641
PUT
SentinelOne
S
$6.22B
| $932K | ﹤0.01% |
40,000
-25,100
| -39% | -$656K |
|
2642
TG Therapeutics
TGTX
$8.53B
| $932K | ﹤0.01% |
61,284
-264,540
| -81% | -$4.21M |
|
2643
Arch Capital
ACGL
$36.3B
| $930K | ﹤0.01% |
10,062
-160,901
| -94% | -$13.6M |
|
|
BPMC
2644
CALL
DELISTED
Blueprint Medicines
BPMC
| $930K | ﹤0.01% |
+9,800
| New | +$840K |
|
2645
CALL
XPO
XPO
$24.4B
| $927K | ﹤0.01% |
+7,600
| New | +$814K |
|
2646
Takeda Pharmaceutical
TAK
$55.7B
| $927K | ﹤0.01% |
66,760
+41,656
| +166% | +$606K |
|
2647
Cemex
CX
$17.6B
| $923K | ﹤0.01% |
102,405
+60,941
| +147% | +$488K |
|
2648
PUT
Avis
CAR
$5.78B
| $918K | ﹤0.01% |
7,500
+5,400
| +257% | +$745K |
|
2649
Harmonic Inc
HLIT
$1.23B
| $917K | ﹤0.01% |
+68,228
| New | +$871K |
|
|
TARO
2650
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $917K | ﹤0.01% |
+21,656
| New | +$912K |
|
Similar funds
Squarepoint's Q1 2024 Portfolio in Review
As of Q1 2024, Squarepoint held 4,799 positions worth $58.1B, up 10% from $52.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Squarepoint's Q1 2024 filing shows 857 new, 1,497 increased, 1,529 reduced and 854 closed positions. Its largest new stake was The Gap Inc: 3,316,943 shares worth $91.4M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.17B.
By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 9.3% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Squarepoint's largest Q1 2024 buy was The Gap Inc: 3,316,943 shares worth $91.4M.
- Squarepoint added most to iShares Core S&P 500 ETF in Q1 2024, an estimated $701M increase.
- Squarepoint's biggest Q1 2024 reduction was Invesco QQQ Trust, cutting an estimated $240M.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q1 2024, selling an estimated $1.17B.
- Squarepoint's ten largest holdings make up 14% of its $58.1B portfolio in Q1 2024.
- Squarepoint opened 857 new positions and closed 854 in Q1 2024.
- Squarepoint's portfolio value rose 10% quarter-over-quarter to $58.1B.
Based on Squarepoint's 13F filing for Q1 2024, filed 15 May 2024.